{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:17:48Z","timestamp":1761718668722},"reference-count":129,"publisher":"Elsevier","isbn-type":[{"value":"9780128136270","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-12-813627-0.00018-1","type":"book-chapter","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:40:04Z","timestamp":1520469604000},"page":"687-722","source":"Crossref","is-referenced-by-count":14,"title":["Nanocarriers for the delivery of temozolomide in the treatment of glioblastoma"],"prefix":"10.1016","author":[{"given":"Maria J.","family":"Ramalho","sequence":"first","affiliation":[]},{"given":"Manuel A.N.","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"Maria C.","family":"Pereira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherited Metab. Disease"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Disease"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1586\/ern.13.42","article-title":"Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies","volume":"13","author":"Ahmed","year":"2013","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/01616412.2015.1133025","article-title":"Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation","volume":"38","author":"Ananta","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib6","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jchromb.2010.05.008","article-title":"Analysis and stability study of temozolomide using capillary electrophoresis","volume":"878","author":"Andrasi","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib7","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1158\/0008-5472.CAN-06-1010","article-title":"Stem cell\u2013like glioma cells promote tumor angiogenesis through vascular endothelial growth factor","volume":"66","author":"Bao","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2016.09.034","article-title":"Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma","volume":"243","author":"Bastiancich","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib10","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1002\/smll.201500540","article-title":"Combined delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells","volume":"11","author":"Bertucci","year":"2015","journal-title":"Small"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/15680096113139990076","article-title":"P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives","volume":"13","author":"Binkhathlan","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.addr.2004.02.014","article-title":"Nanoparticle and targeted systems for cancer therapy","volume":"56","author":"Brannon-Peppas","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00280-006-0407-2","article-title":"Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model","volume":"60","author":"Brem","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib14","first-page":"739","article-title":"PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy","volume":"10","author":"Byeon","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.brainresrev.2010.05.003","article-title":"Looking at the blood\u2013brain barrier: molecular anatomy and possible investigation approaches","volume":"64","author":"Cardoso","year":"2010","journal-title":"Brain Res. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1586\/ern.10.32","article-title":"Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas","volume":"10","author":"Chamberlain","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib17","first-page":"34","article-title":"Polylactides\/glycolides-excipients for injectable drug delivery and beyond","volume":"2","author":"Chaubal","year":"2002","journal-title":"Drug Deliv. Technol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood\u2013brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3109\/10717544.2015.1038857","article-title":"Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy","volume":"23","author":"Chen","year":"2016","journal-title":"Drug Delivery"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib20","doi-asserted-by":"crossref","first-page":"12486","DOI":"10.1073\/pnas.1517048112","article-title":"Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core","volume":"112","author":"Clark","year":"2015","journal-title":"Proc. Natl Acad. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2015.06.034","article-title":"Supramolecular nanoscale assemblies for cancer diagnosis and therapy","volume":"213","author":"Coelho","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/030089160609200407","article-title":"Temozolomide and radiotherapy as first-line treatment of high-grade gliomas","volume":"92","author":"Corsa","year":"2006","journal-title":"Tumori"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.138.4.877","article-title":"A new function for the LDL receptor: transcytosis of LDL across the blood\u2013brain barrier","volume":"138","author":"Dehouck","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib27","first-page":"179","article-title":"Targeted drug delivery to CNS using nanoparticles","volume":"2","author":"Dikpati","year":"2012","journal-title":"J. Adv. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejpb.2013.07.013","article-title":"Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model","volume":"85","author":"Dilnawaz","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2014.08.014","article-title":"Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy","volume":"474","author":"Di Martino","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejps.2016.05.001","article-title":"Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide","volume":"92","author":"Di Martino","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib29","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib30","series-title":"Diagnostic Neuropathology: A Practical Manual","author":"Esiri","year":"1989"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13046-015-0216-8","article-title":"Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions","volume":"34","author":"Fan","year":"2015","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib32","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1021\/am5092165","article-title":"Temozolomide nanoparticles for targeted glioblastoma therapy","volume":"7","author":"Fang","year":"2015","journal-title":"ACS Appl. Mater. Interf."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.phrs.2010.02.004","article-title":"Nano-interventions for neurodegenerative disorders","volume":"62","author":"Fernandes","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0169-409X(96)00453-X","article-title":"The design and development of DaunoXome\u00ae for solid tumor targeting in vivo","volume":"24","author":"Forssen","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib35","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/jbm.a.35286","article-title":"Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells","volume":"103","author":"Frasco","year":"2015","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib36","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2005.11.040","article-title":"Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"310","author":"Gao","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5582\/ddt.2015.01016","article-title":"Liposome encapsulated of temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation","volume":"9","author":"Gao","year":"2015","journal-title":"Drug Discov. Therap."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3109\/1061186X.2011.589435","article-title":"Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers","volume":"19","author":"Geldenhuys","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrc2246","article-title":"Making a tumour's bed: glioblastoma stem cells and the vascular niche","volume":"7","author":"Gilbertson","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib41","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00520-014-2384-z","article-title":"Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs","volume":"22","author":"Golla","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/neuonc\/2.1.45","article-title":"The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery","volume":"2","author":"Groothuis","year":"2000","journal-title":"Neuro-oncology"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.seminoncol.2004.07.005","article-title":"Current management of glioblastoma multiforme","volume":"31","author":"Grossman","year":"2004","journal-title":"Semin. Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib44","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1208\/s12249-014-0165-0","article-title":"Brain-targeted delivery of docetaxel by glutathione-coated nanoparticles for brain cancer","volume":"15","author":"Grover","year":"2014","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib45","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib46","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bcp.2012.01.008","article-title":"Nanoparticle-based combination therapy toward overcoming drug resistance in cancer","volume":"83","author":"Hu","year":"2012","journal-title":"Biochem. Pharm."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib47","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3892\/ijmm.2016.2458","article-title":"Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells","volume":"37","author":"Hu","year":"2016","journal-title":"Int. J. Molec. Med."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijpharm.2007.12.013","article-title":"Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity","volume":"355","author":"Huang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-8993(98)00634-9","article-title":"Decreased endothelial cell glutathione and increased sensitivity to oxidative stress in an in vitro blood\u2013brain barrier model system","volume":"802","author":"Hurst","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib50","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.dnarep.2007.03.013","article-title":"MGMT hypermethylation: a prognostic foe, a predictive friend","volume":"6","author":"Jacinto","year":"2007","journal-title":"DNA Repair"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib56","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2217\/nnm.12.86","article-title":"Nanobiotechnology-based strategies for crossing the blood-brain barrier","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib51","doi-asserted-by":"crossref","first-page":"e25102","DOI":"10.4161\/biom.25102","article-title":"Formulation and optimization of temozolomide nanoparticles by 3 factor 2 level factorial design","volume":"3","author":"Jain","year":"2013","journal-title":"Biomatter"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/02652048.2010.522257","article-title":"Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation","volume":"28","author":"Jain","year":"2011","journal-title":"J. Microencapsulat."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-1518-4","article-title":"Transferrin-tailored solid lipid nanoparticles as vectors for site-specific delivery of temozolomide to brain","volume":"15","author":"Jain","year":"2013","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biomag.2013.08.003","article-title":"Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells","volume":"3","author":"Jain","year":"2013","journal-title":"Biomed. Aging Pathol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2008-2231-22-18","article-title":"Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles","volume":"22","author":"Jain","year":"2014","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/era.12.37","article-title":"Molecular mechanisms of temozolomide resistance in glioblastoma multiforme","volume":"12","author":"Johannessen","year":"2012","journal-title":"Exp. Rev. Anticancer Ther."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00018-007-6390-x","article-title":"Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells","volume":"64","author":"Kim","year":"2007","journal-title":"Cell. Molec. Life Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib59","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2015.08.022","article-title":"Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma","volume":"369","author":"Kim","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","article-title":"Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?","volume":"71","author":"Kreuter","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2006.12.012","article-title":"Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain","volume":"118","author":"Kreuter","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2012.04.044","article-title":"Challenges in drug delivery to the brain: nature is against us","volume":"164","author":"Krol","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib63","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib65","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3109\/1061186X.2013.812094","article-title":"Solid lipid nanoparticles carrying chemotherapeutic drug across the blood\u2013brain barrier through insulin receptor-mediated pathway","volume":"21","author":"Kuo","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/ph9030054","article-title":"Preparation of temozolomide-loaded nanoparticles for glioblastoma multiforme targeting\u2014ideal versus reality","volume":"9","author":"Lee","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib67","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1200\/JCO.2005.03.089","article-title":"Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis","volume":"23","author":"Lefranc","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib68","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1387\/ijdb.103224sl","article-title":"Current concepts of blood-brain barrier development","volume":"55","author":"Liebner","year":"2011","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib69","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2012.03.047","article-title":"Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma","volume":"430","author":"Ling","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DDC-120001481","article-title":"Nanoparticle technology for drug delivery across the blood-brain barrier","volume":"28","author":"Lockman","year":"2002","journal-title":"Drug Dev. Industr. Pharm."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2003.08.006","article-title":"Brain uptake of thiamine-coated nanoparticles","volume":"93","author":"Lockman","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib72","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood\u2013brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib74","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2217\/nnm.14.27","article-title":"Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies","volume":"9","author":"Loureiro","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib75","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.colsurfb.2015.06.067","article-title":"Dual ligand immunoliposomes for drug delivery to the brain","volume":"134","author":"Loureiro","year":"2015","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib76","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.04.041","article-title":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer\u2019s disease treatment","volume":"145","author":"Loureiro","year":"2016","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib77","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polym. (Basel)"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib78","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.phrs.2007.08.003","article-title":"Triazene compounds: mechanism of action and related DNA repair systems","volume":"56","author":"Marchesi","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib79","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/1389200211314060001","article-title":"Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier","volume":"14","author":"Martha Leonor","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1155\/2013\/238428","article-title":"Nanoparticles for brain drug delivery","volume":"2013","author":"Masserini","year":"2013","journal-title":"ISRN Biochem."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib81","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"McLendon","year":"2008","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157488912798842241","article-title":"Lipid-based nanocarriers for CNS-targeted drug delivery","volume":"7","author":"Micheli","year":"2012","journal-title":"Recent Patents CNS Drug Discov."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib83","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.jns.2015.08.630","article-title":"Treatment and prognosis of glioblastoma multiforme: a literature review","volume":"357","author":"Morais","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib84","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.msec.2016.07.080","article-title":"Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: a review","volume":"69","author":"Mujokoro","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib85","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib86","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nec.2012.01.007","article-title":"Temozolomide and other potential agents for the treatment of glioblastoma multiforme","volume":"23","author":"Nagasawa","year":"2012","journal-title":"Neurosurg. Clin. North Am."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib87","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF02219299","article-title":"The reactivity and mechanism of action of triazenes (review)","volume":"28","author":"Nifontov","year":"1994","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib88","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib89","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"Journal of Cerebral Blood Flow & Metabolism."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib90","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1471-4159.1985.tb07167.x","article-title":"Human blood\u2014brain barrier insulin receptor","volume":"44","author":"Pardridge","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib91","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0026-0495(87)90099-0","article-title":"Human blood-brain barrier transferrin receptor","volume":"36","author":"Pardridge","year":"1987","journal-title":"Metabolism"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib92","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2012.05.010","article-title":"Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy","volume":"17","author":"Parhi","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib93","first-page":"5","article-title":"Formulation development and evaluation of temozolomide loaded hydrogenated soya phosphatidylcholine liposomes for the treatment of brain cancer","volume":"9","author":"Parikh","year":"2016","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10717544.2013.801050","article-title":"Development and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker","volume":"20","author":"Patel","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib95","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s11095-010-0091-0","article-title":"Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(beta-L-malic acid)","volume":"27","author":"Patil","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib96","first-page":"1","article-title":"Nanomedicines for cancer therapy: an update of FDA approved and those under various stages of development","volume":"1","author":"Pillai","year":"2014","journal-title":"SOJ Pharm. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib98","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopha.2015.12.014","article-title":"Nanoparticles: novel vehicles in treatment of Glioblastoma","volume":"77","author":"Pourgholi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib99","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/acs.jchemed.5b00837","article-title":"Preparation and characterization of polymeric nanoparticles: an interdisciplinary experiment","volume":"93","author":"Ramalho","year":"2016","journal-title":"J. Chem. Educat."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib100","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3762\/bjnano.6.135","article-title":"PLGA nanoparticles as a platform for vitamin D-based cancer therapy","volume":"6","author":"Ramalho","year":"2015","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib102","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/neuonc\/nos153","article-title":"A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme","volume":"14","author":"R\u00f8nning","year":"2012","journal-title":"Neuro-Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib101","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/jcbfm.2011.197","article-title":"Neurological diseases in relation to the blood\u2013brain barrier","volume":"32","author":"Rosenberg","year":"2012","journal-title":"J. Cerebral Blood Flow Metab."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib103","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.nano.2010.02.002","article-title":"In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems","volume":"6","author":"Semete","year":"2010","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib104","first-page":"30","article-title":"Recent biomedical applications and patents on biodegradable polymer-PLGA","volume":"1","author":"Singh","year":"2014","journal-title":"Int. J. Pharmacol. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00109-013-1019-z","article-title":"Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme","volume":"91","author":"Soda","year":"2013","journal-title":"J. Molec. Med."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib106","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3109\/10717544.2015.1064186","article-title":"Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy","volume":"23","author":"Song","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib107","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","article-title":"A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics","volume":"48","author":"Steichen","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib108","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/jm00368a016","article-title":"Antitumour imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agent","volume":"27","author":"Stevens","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib109","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(01)00489-2","article-title":"Current and future developments in the use of temozolomide for the treatment of brain tumours","volume":"2","author":"Stupp","year":"2001","journal-title":"The Lancet Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib111","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11910-005-0047-7","article-title":"Optimal role of temozolomide in the treatment of malignant gliomas","volume":"5","author":"Stupp","year":"2005","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib112","first-page":"1264","article-title":"Nanobiotechnology-based drug delivery in brain targeting","volume":"14","author":"Subas","year":"2013","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib113","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/OTT.S50208","article-title":"Personalized treatment strategies in glioblastoma: MGMT promoter methylation status","volume":"6","author":"Thon","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib114","series-title":"Fundamentals and Applications of Controlled Release Drug Delivery.","article-title":"Liposomes in drug delivery","author":"Torchilin","year":"2012"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611861003734001","article-title":"Targeting the insulin receptor: nanoparticles for drug delivery across the blood\u2013brain barrier (BBB)","volume":"19","author":"Ulbrich","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib117","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.addr.2007.06.003","article-title":"Biodegradable nanoparticles for cytosolic delivery of therapeutics","volume":"59","author":"Vasir","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib118","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbcan.2013.07.001","article-title":"Invasion as target for therapy of glioblastoma multiforme","volume":"1836","author":"Vehlow","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Rev. Cancer"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib119","first-page":"157","article-title":"Blood-brain-barrier co-culture models to study nanoparticle penetration: focus on co-culture systems","volume":"59","author":"Veszelka","year":"2015","journal-title":"Acta Biol. Szegediensis"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib121","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2010.03.005","article-title":"Targeting nanoparticles to cancer","volume":"62","author":"Wang","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib122","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"New Engl. J. Med."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib123","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3174\/ajnr.A2170","article-title":"Temozolomide (Temodar)","volume":"31","author":"Wesolowski","year":"2010","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib120","series-title":"World Health Statistics 2016: Monitoring Health for the SDGs, Sustainable Development Goals","author":"WHO","year":"2016"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib124","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","article-title":"Transport of drugs across the blood\u2013brain barrier by nanoparticles","volume":"161","author":"Wohlfart","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib125","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3109\/10717544.2015.1058434","article-title":"Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery","volume":"23","author":"Wu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib126","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.18632\/oncotarget.7896","article-title":"The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib127","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/07357907.2013.861474","article-title":"Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review","volume":"32","author":"Yang","year":"2014","journal-title":"Cancer Investig."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib128","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.115.012070","article-title":"Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come","volume":"68","author":"Yingchoncharoen","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib129","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3892\/ijo_00000621","article-title":"Gene expression profiling predicts response to temozolomide in malignant gliomas","volume":"36","author":"Yoshino","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00018-1_bib130","first-page":"1658","article-title":"Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma","volume":"8","author":"Zheng","year":"2015","journal-title":"Int. J. Clin. Exp. Med."}],"container-title":["Design and Development of New Nanocarriers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136270000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136270000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T03:02:18Z","timestamp":1603940538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128136270000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128136270"],"references-count":129,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-813627-0.00018-1","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}